Asian Patients with Genotype 1 HCV Infection Achieve 99% Sustained Virologic Response with 12 Weeks of Ledipasvir/Sofosbuvir Single Tablet Regimen: Integrated analysis of Phase 3 Multicenter Studies

臺大醫學院;臺大醫學院-臨床醫學研究所;Mizokami, MasashiMasashiMizokamiChuang, Wan-LongWan-LongChuangHan, Kwang-HyubKwang-HyubHanLim, Young-SukYoung-SukLimYang, Jenny C.Jenny C.YangDe-Oertel, ShampaShampaDe-OertelGao, BingBingGaoMo, HongmeiHongmeiMoPang, Phillip S.Phillip S.PangKnox, Steven J.Steven J.KnoxMcHutchison, John G.John G.McHutchisonOmata, MasaoMasaoOmataKao, Jia-HorngJia-HorngKao2017-06-222018-07-062017-06-222018-07-062015http://ntur.lib.ntu.edu.tw//handle/246246/279862Asian Patients with Genotype 1 HCV Infection Achieve 99% Sustained Virologic Response with 12 Weeks of Ledipasvir/Sofosbuvir Single Tablet Regimen: Integrated analysis of Phase 3 Multicenter Studies